Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkins Lymphoma Post CAR-T Treatment

Study Summary

This study evaluates immune responses after CAR-T therapy to find out if CAR-T therapy reduces the effectiveness of the vaccines (vaccine immunity) against diseases such as measles, mumps and rubella, among others in patients with multiple myeloma and non-Hodgkin lymphoma.

Interventions

Study Locations

Facility	City	State	Country
OHSU Knight Cancer Institute	Portland	Oregon	United States

Official Trial Information

View on ClinicalTrials.gov